A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer
- PMID: 22996169
- PMCID: PMC3897718
- DOI: 10.1002/sim.5629
A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer
Abstract
Breast cancer patients may experience ipsilateral breast tumor relapse (IBTR) after breast conservation therapy. IBTR is classified as either true local recurrence or new ipsilateral primary tumor. The correct classification of IBTR status has significant implications in therapeutic decision-making and patient management. However, the diagnostic tests to classify IBTR are imperfect and prone to misclassification. In addition, some observed survival data (e.g., time to relapse, time from relapse to death) are strongly correlated with IBTR status. We present a Bayesian approach to model the potentially misclassified IBTR status and the correlated survival information. We conduct the inference using a Bayesian framework via Markov chain Monte Carlo simulation implemented in WinBUGS. Extensive simulation shows that the proposed method corrects biases and provides more efficient estimates for the covariate effects on the probability of IBTR and the diagnostic test accuracy. Moreover, our method provides useful subject-specific patient prognostic information. Our method is motivated by, and applied to, a dataset of 397 breast cancer patients.
Copyright © 2012 John Wiley & Sons, Ltd.
Figures


Similar articles
-
Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event.Stat Med. 2014 Jul 10;33(15):2554-66. doi: 10.1002/sim.6101. Epub 2014 Jan 29. Stat Med. 2014. PMID: 24473943 Free PMC article.
-
Simultaneous inference of a misclassified outcome and competing risks failure time data.J Appl Stat. 2015;42(5):1080-1090. doi: 10.1080/02664763.2014.995606. J Appl Stat. 2015. PMID: 25821331 Free PMC article.
-
True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management.Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1281-9. doi: 10.1016/s0360-3016(00)01378-x. Int J Radiat Oncol Biol Phys. 2000. PMID: 11121624
-
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.Ann Surg. 2011 Mar;253(3):572-9. doi: 10.1097/SLA.0b013e318208fc2a. Ann Surg. 2011. PMID: 21209588 Free PMC article.
-
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.Breast Cancer. 2005;12(2):104-11. doi: 10.2325/jbcs.12.104. Breast Cancer. 2005. PMID: 15858440
Cited by
-
Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event.Stat Med. 2014 Jul 10;33(15):2554-66. doi: 10.1002/sim.6101. Epub 2014 Jan 29. Stat Med. 2014. PMID: 24473943 Free PMC article.
-
Fast Variational Bayesian Inference for Correlated Survival Data: An Application to Invasive Mechanical Ventilation Duration Analysis.Stat Med. 2025 Jul;44(15-17):e70198. doi: 10.1002/sim.70198. Stat Med. 2025. PMID: 40708175 Free PMC article.
-
Simultaneous inference of a misclassified outcome and competing risks failure time data.J Appl Stat. 2015;42(5):1080-1090. doi: 10.1080/02664763.2014.995606. J Appl Stat. 2015. PMID: 25821331 Free PMC article.
References
-
- Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, W N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New England Journal of Medicine. 2002;347:1233–41. doi: 10.1056/NEJMoa022152. - DOI - PubMed
-
- Chen AM, Meric-Bernstam F, Hunt KK, Thames H, Oswald MJ, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, et al. Breast conservation after neoadjuvant chemotherapy: the MD Anderson Cancer Center experience. Journal of Clinical Oncology. 2004;22:2303–12. doi: 10.1200/JCO.2004.09.062. - DOI - PubMed
-
- Fowble B, Solin LJ, Schultz DJ, Rubenstein J, Goodman RL. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. International Journal of Radiation Oncology. 1990;19:833–42. doi: 10.1016/0360-3016(90)90002-2. - DOI - PubMed
-
- Rouzier R, Extra JM, Carton M, Falcou MC, Vincent-Salomon A, Fourquet A, Pouillart P, B E. Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. Journal of Clinical Oncology. 2001;19:3828–35. - PubMed
-
- Van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. Journal of the National Cancer Institute. 2000;92:1143–50. doi: 10.1093/jnci/92.14.1143. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical